Search

The article offers step-by-step instructions for skin script skin care and estheticpro and advanced lightstim and PCA skin professional peel treatment for aging skin.

Monitoring the concentration of glucocorticoid metabolites (GCMs) in faecal samples is a noninvasive tool for physiological stress evaluation, particularly useful when studying wild species. However, both negative and positive stimuli (distress and eustress, respectively) can lead to a rise in glucocorticoids. Thus, besides validating whether GCM concentration in faeces reflects endogenous adrenal activity, we also need to identify behavioural indicators of distress to avoid misinterpretation. Therefore, we submitted four adult male spotted pacas (Cuniculus paca) to an exogenous adrenocorticotropic hormone (ACTH) challenge-test in a Latin square design (4 × 4) to monitor changes in the GCM concentration in faeces. We also aimed to describe behaviours potentially indicative of distress. We collected excreted faeces and video-recorded the animals' behaviours for five consecutive days, one day before and four days after application of the following four treatments: 1st control (no-handling); 2nd control (intra-muscular [IM] injection of saline solution); low-dose ACTH (IM injection of 0.18 ml ACTH); and high-dose ACTH (IM injection of 0.37 ml ACTH). There was a peak in the concentration of GCM in faeces collected 24 h after the injection of the high-doseACTH treatment. Additionally, independent of the treatments, spotted pacas spent less time on exploration and feeding states, while spending more time in the inactive but awake (IBA) state following the treatment application (challenge day). The use of GCM concentration in faecal samples together with the behavioural changes (less exploration and feeding, and more IBA) showed to be efficient as a non-invasive tool for welfare assessment of farmed spotted paca. [ABSTRACT FROM AUTHOR]

A patent has been issued for a drain apparatus for hemodialysis machines. Hemodialysis is a treatment used to support patients with insufficient renal function, and it involves passing the patient's blood through a dialyzer in a dialysis machine. The dialysis machine acts as an artificial kidney, removing waste products from the blood. The drain apparatus is designed to empty the contents of the blood line set and fill it with disinfectant fluid. The patent was filed by inventors from Walnut Creek, CA, Pleasanton, CA, and Hudson, NH, and assigned to Fresenius Medical Care Holdings Inc. [Extracted from the article]

This patent application discusses the development of formulations for radiopharmaceuticals used in radiotherapy and diagnostic imaging. The inventors address challenges such as premature dissociation of the radioisotope from the ligand, radiolysis of the ligand, and the need for solubility in a pharmaceutically acceptable solvent. The application proposes specific aqueous formulations for parenteral administration that include compounds of Formula (I) complexed with a Cu ion, along with ethanol, sodium chloride, and gentisic acid or L-methionine. The invention also includes kits for preparing these formulations. [Extracted from the article]

Researchers at Saratov State University have conducted a study on the development of more advanced dosage and delivery systems for antibiotics. They created emulsion microgels (EM) containing antibacterial drugs and studied their effects on E. coli. The researchers found that the immobilization of antibiotics into EM increased the duration and intensity of their action without decreasing their effectiveness. This research provides valuable insights into the potential use of emulsion microgels as carriers for antibacterial drugs. [Extracted from the article]

A study conducted by researchers from Hiroshima International University aimed to assess the risk of electric shock to the general public when a defibrillation shock is inadvertently delivered without Personal Protective Equipment (PPE). The study simulated different scenarios and measured the voltage and current across the rescuer. The results showed that in a simulated setting, over 300 mA of current could pass through the rescuer without PPE when there are two contact points between the rescuer and the patient. However, due to the brief duration and low energy, immediate danger to the rescuer is considered low. [Extracted from the article]

A new study conducted by researchers at the State University of Ceara in Brazil has found that exposure to second-hand cigarette smoke can cause significant damage to the respiratory system, similar to active tobacco consumption. The study also explored the potential benefits of using eucalyptol as a preventive measure against lung damage caused by cigarette smoke. The experiments were conducted on mice, and the results showed that pre-treatment with eucalyptol was able to prevent the changes caused by second-hand smoke. This research suggests that eucalyptol could be used as a preventive or nutritional resource to mitigate the harmful effects of cigarette smoke. [Extracted from the article]

Researchers at the University of Ferrara in Italy conducted a study on the permeation of propofol, a sedative, across nasal mucosa. The study aimed to achieve light sedation through intranasal administration. However, the researchers found that propofol did not permeate across the rabbit nasal mucosa in the ex vivo study. Despite attempts to increase solubility and diffusion with the use of cyclodextrin, the amount of propofol that permeated was minimal. The study highlights the importance of formulation and the need for innovation in drug delivery techniques to optimize therapeutic efficacy. [Extracted from the article]

This document provides information about a clinical trial for the treatment of glioblastoma, a type of brain cancer. The trial is investigating the use of a device called Optune, along with the drugs Temozolomide and Pembrolizumab, in combination with standard chemotherapy and radiation therapy. The trial is currently not recruiting participants and aims to enroll 741 individuals. The eligibility criteria for participants are outlined, and the trial is being conducted by NovoCure Ltd. in collaboration with Merck Sharp & Dohme LLC. The document also includes administrative information such as the study ID number and contact details for the primary investigator. [Extracted from the article]

A patent has been issued to CareFusion 303 Inc. for a system that fills containers with medical fluids. The system aims to minimize the transportation of filled containers by allowing them to be filled locally at decentralized locations. The system includes a container assembly with multiple containers and a fluid manifold that provides fluid communication between the containers. The patent describes various embodiments of the system and its components. This information may be useful for researchers studying healthcare technology and looking for innovative solutions in the field. [Extracted from the article]

This patent application discusses an innovative system and method for unclogging working channels in medical devices, specifically endoscopes. Endoscopes are used by doctors to visualize and remove unwanted tissue or foreign objects from a patient's body. The described system includes an irrigation source and a suction source that can be connected to the working channels. A controller circuit is used to alternate between irrigating the channels and applying suction pressure to unclog them. Sensors are also incorporated to detect clogging and adjust flow rates or pressure to maintain optimal conditions during the medical procedure. For more in-depth information and specific claims, the full patent application should be consulted. [Extracted from the article]

A patent application has been submitted for a method of removing blood from an extracorporeal blood circuit following a blood treatment session. The method involves introducing a substituate liquid into the circuit and using a blood pump and a second conveying means to concurrently discharge blood from both the arterial and venous conduit portions of the circuit. The invention is not limited to any specific blood treatment and can be used in various extracorporeal blood treatments. The patent application provides detailed information on the method and its implementation. [Extracted from the article]

A patent has been issued to B. Braun Avitum AG for a method and device for automated priming of an extracorporeal blood conduit system. The invention aims to improve and partially automate the preparation process for extracorporeal blood treatment, such as dialysis. The method involves connecting the arterial and venous blood lines of the system to a blood treatment unit and filling the system with priming liquid. The pump segment is automatically occluded by a blood pump after filling with priming liquid. The invention provides a more efficient and air-free priming process for extracorporeal blood treatment. [Extracted from the article]

Researchers from Complutense University Madrid have conducted a study on the histological impact of nebulized tocilizumab, a monoclonal antibody used to treat rheumatoid arthritis and severe COVID-19, on a murine model. The study found that nebulized tocilizumab did not cause significant histological changes in the liver, indicating its safety. The researchers suggest that nebulized tocilizumab has potential for treating pulmonary inflammation and further research is needed to establish its efficacy and safety in clinical settings. The study was published in the journal Pharmaceutics. [Extracted from the article]

A recent study conducted at the Hospital for Special Surgery in New York City explored the effects of antiseptic irrigation solutions on osseointegration in a cementless tibial implantation mouse model. The researchers aimed to determine the optimal solution concentration that balances bactericidal activity and osseointegration. The study involved 40 mice that underwent tibial implantation surgery and were divided into three groups receiving different irrigation solutions. The results showed that both antiseptic irrigation solutions were safe to use during joint arthroplasty without compromising osseointegration or causing wound complications. This research provides valuable insights for the development of more effective antiseptic solutions in reducing periprosthetic joint infection rates. [Extracted from the article]

A 21-year-old woman experienced pneumorrhachis, or air in the spinal canal, as a result of an incorrect injection technique during the administration of bupivacaine for epidural anesthesia during delivery. The woman had a history of a previous caesarean section and was admitted at 38 weeks of gestation. After the delivery, she complained of severe pain in the lumbar area and a thoracolumbar CT scan confirmed the diagnosis of pneumorrhachis. Supportive care was provided and the condition resolved after 8 hours. The case highlights the potential complications associated with epidural anesthesia and the importance of proper injection techniques. [Extracted from the article]

A study conducted at the University of Novi Sad in Serbia examined the effectiveness of tranexamic acid (TXA) in reducing perioperative blood loss in patients undergoing total knee arthroplasty (TKA). The study included 96 patients who were randomly assigned to two groups, with one group receiving intravenous TXA and the other receiving a saline solution. The results showed that TXA significantly reduced blood loss and the need for blood transfusion in the TXA group compared to the control group. Additionally, patients who received TXA had better postoperative functional recovery. The study concluded that TXA is an effective drug for reducing bleeding, transfusion rates, and improving recovery in TKA patients. [Extracted from the article]

In a retrospective study involving 8 patients, a male patient with a multi-resistant gram negative bacterial infection was treated with cefiderocol but did not experience efficacy. The patient received cefiderocol through prolonged infusion but did not achieve microbiological success. This study suggests that cefiderocol may not be effective in treating multi-resistant gram negative bacterial infections. [Extracted from the article]

A patent has been issued for a method and devices for the calibration of a pump used in blood treatment. The patent, filed by inventors Josef Beden and Juergen Klewinghaus, describes a method for determining the actual pump rate and calibrating a blood pump connected to an extracorporeal blood circuit. The method involves providing a blood pump connected to a fluid source and a reception unit, operating the pump at a set rate to convey fluid into the reception unit, and determining the actual volume conveyed based on a change in weight. The patent is assigned to Fresenius Medical Care Deutschland GmbH. [Extracted from the article]

A recent study conducted by researchers at Kutahya Health Sciences University examined the effects of different irrigant activation techniques (IAT) using two chelating agents, 17% ethylenediaminetetraacetic acid (EDTA) and 9% etidronic acid (HEDP), on the release of growth factors (GFs) from dentin. The study found that both EDTA and HEDP increased GF release, with the EDDY IAT method being the most effective. The researchers suggest that using chelating agents with IAT may be beneficial in regenerative endodontic treatments. This study provides valuable insights into the role of irrigation solutions in the release of GFs for dental pulp stem cell regeneration. [Extracted from the article]

An 11-year-old girl with neurogenic constipation and fecal incontinence experienced lack of efficacy and developed new-onset vomiting, abdominal distention, and abdominal pain during treatment with bisacodyl, glycerol, PEG-3350, and sodium-chloride. Despite treatment, her bowel evacuation did not occur, and she required cone enemas to empty her rectum. After resuming treatment, the same symptoms occurred, leading to a diagnostic laparoscopy that revealed adhesions causing a hairpin obstruction. The girl underwent colostomy creation and remained well afterward. [Extracted from the article]

This document provides information about a clinical trial (NCT06433596) that is currently recruiting participants to investigate the effectiveness and safety of combining platelet-rich plasma (PRP) with shock-wave therapy (SWT) for the treatment of erectile dysfunction. The trial aims to enroll 116 men and will compare the combined therapy to a placebo therapy. Participants will undergo lab tests, answer questionnaires, and receive either the combined therapy or placebo therapy for 9 weeks. Follow-up visits will be conducted at one month, three months, and six months after treatment completion. The trial is expected to be completed by December 2026 and is being conducted by Elexial Research Limited in collaboration with Boston Medical Group. [Extracted from the article]

A recent veterinary research study conducted at Khon Kaen University in Thailand explored the potential efficacy of low-level laser therapy (LLLT) in cats. The study focused on the extraoral application technique, which was found to provide more comfort compared to intraoral application. The researchers investigated the penetration efficacy of LLLT using 830 nm continuous waves with various settings and different application techniques. The study concluded that extraoral application of LLLT demonstrated penetration efficacy through the buccal tissue and could be a potential alternative treatment for oral diseases in clinical practice. However, further research is needed to determine the efficacy of this treatment in a clinical setting. [Extracted from the article]

Zetagen Therapeutics Inc. has been issued a patent for methods and compositions for treating cancer. The patent describes a method of treating cancer by locally administering an opioid growth factor receptor (OGFR) antagonist to a site containing cancer cells. The composition may include naloxone, naltrexone, or a derivative or analog thereof. The patent also discusses the use of a hydrogel carrier and a diluent to enhance the solubility of the OGFR antagonist. The invention aims to provide a novel treatment strategy for various types of cancer, including triple negative breast carcinoma. [Extracted from the article]

A recent study conducted by researchers at the Federal University of ABC in Santo Andre, Brazil, explores the relationship between tribocorrosion and surface chemistry of ASTM F139 surgical stainless steel in a phosphate-buffered saline solution. The study found that wear volume was dependent on the electrochemical potential, with the highest wear observed at +700 mVAg/AgCl. Delamination areas and grooves were observed in the wear tracks, and analysis of the surface chemistry allowed for correlation of the passive film composition with the observed tribocorrosion behavior. This research provides valuable insights into the behavior of surgical stainless steel in biomedical applications. [Extracted from the article]

A study conducted at the University of Catania aimed to evaluate the effects of using a cool saline solution irrigation after mandibular third molar extraction on postoperative complications. The study involved 17 healthy participants who required bilateral mandibular third molar extraction. One impacted third molar was designated as the experimental group and subjected to saline lavage at 4 °C, while the other impacted third molar served as the control group and underwent saline lavage at 25 °C. The study found that using a cool saline solution irrigation effectively reduced early postoperative complications, particularly pain, without prolonging surgical duration. [Extracted from the article]

A recent study conducted by the University of Michigan investigated the effects of saline submersion at body temperature on various airway supportive devices, including a novel nasopharyngeal device produced using 3D-printing. The study found that the dimensions of cuffless Covidien endotracheal tubes, pediatric Rusch fixed flange polyvinyl chloride nasal airway tubes, and the novel silicone elastomer self-supporting nasopharyngeal airways did not change significantly over 15 days. However, the pediatric Rusch Robertazzi style Mediprene nasal airway tubes experienced a significant increase in length and wall thickness after one day of submersion, indicating a risk of expansion during extended use. The study suggests that silicone and PVC materials may be more appropriate for extended use. [Extracted from the article]

A 50-year-old woman experienced worsening rhabdomyolysis while being treated with haloperidol for psychotic episodes. She had a history of complications during childbirth and subsequent health issues, including muscle weakness, loss of hair, and loss of libido. Blood tests revealed abnormalities such as anemia, muscle damage, and electrolyte imbalances. After being transferred to the endocrinology department, she was diagnosed with Sheehan syndrome and treated with levothyroxine and hydrocortisone, which resolved her symptoms. [Extracted from the article]

A boy with a history of alport syndrome underwent a renal transplant and was treated with immunosuppressive therapy. After nine years, he developed human papillomavirus (HPV) cutaneous warts on his hands. Various treatments were attempted, but the warts were resistant. Acitretin was then prescribed, but the boy experienced xerosis and pruritus as side effects, leading to the discontinuation of the medication. Finally, intralesional cidofovir injections were administered, which significantly resolved the lesions. The boy remained free of recurrence during follow-up. [Extracted from the article]

It was investigated how many cattle become infected with Trypanosoma vivax by subcutaneous (SC), intramuscular (IM) and intravenous (IV) routes, using the same syringe and needle from an animal with acute T. vivax infection. Besides, the T. vivax viability in 109 injectable veterinary drugs (antibiotics, antiparasitics, reproductive hormones, vitamin complex and derivatives, vaccines, anaesthetics, anti-inflammatory/antipyretics, antitoxics). In the field assay, four groups were performed: T01, T02 and T03 animals that received saline solution with the same syringe and needle contaminated with T. vivax via SC, IM and IV routes, respectively, and T04 control animals that received only saline solution with the same syringe and needle IV. In the laboratory, drugs had their pH measured and T. vivax viability verified. The number of cattle infected with T. vivax via SC (3/20) was lower (P ≤ 0.05) compared to via IM (9/20), which was lower (P ≤ 0.05) compared to IV (15/20). The solution pH did not influence T. vivax viability. In 44% (48/109) of the products, T. vivax remained viable regardless of time, stooding out that in 100% of oxytocins the protozoan was verified, at some evaluation times. The mean of T. vivax quantified in foot-and-mouth and brucellosis vaccines and in doramectin-based products were higher (P ≤ 0.05) than found in blood + saline solution. [ABSTRACT FROM AUTHOR]

This article provides information about a clinical trial, NCT06302335, taking place in a large university hospital in Southern Brazil. The trial aims to compare the rates of surgical site infection (SSI) in patients undergoing colorectal surgeries. The study is currently recruiting participants and will randomize them into two groups, one receiving povidone-iodine irrigation and the other receiving saline solution irrigation. The trial is in the interventional phase and is designed to prevent SSI. The study is being conducted at the Hospital de Clinicas de Porto Alegre, with Daniel C Damin as the primary contact. [Extracted from the article]

A study conducted by researchers at Beijing University of Technology investigated the effect of saline solutions on the shear strength of compacted bentonite, which is important for assessing the safety of engineering barriers in deep geological repositories. The study found that the shear strength of the specimens increased with increasing vertical stress or solution concentration. The saturation method used for the specimens affected the shear strength, with distilled water resulting in higher shear strength when using the constant-volume method, and salt solutions resulting in higher shear strength when using the constant-vertical stress method. The microstructure of the compacted bentonite was also affected by the salt solution concentration. The study concluded that the salt solution concentration affects the microstructure and interparticle stress of compacted bentonite. [Extracted from the article]

Researchers at Federal University Rio Grande do Sul in Porto Alegre, Brazil have conducted a clinical study comparing autologous serum eye drops diluted with 0.5% methylcellulose and 0.9% saline solution. The study evaluated subjective criteria for symptom improvement and objective clinical criteria for response to therapy. The results showed that autologous serum in 0.9% saline was not inferior to the methylcellulose formulation and is more cost-effective. This study supports the use of autologous serum as a successful treatment for severe dry eye disease resistant to conventional therapy. [Extracted from the article]

A patent has been issued for an irrigation and aspiration device and method developed by Aardvark Medical Inc. The device aims to address nasal and sinus congestion, which is a common problem for both children and adults. Current strategies for congestion relief, such as over-the-counter and prescription medications, have limitations and side effects. The device combines saline irrigation and suctioning to provide relief, especially for infants with bronchiolitis. It offers improved control, ease of use, and diagnostic capabilities. The device includes a source of saline solution, an effluent receptacle, a nasal interface, a fluid passageway, and a switch assembly for controlling the flow of saline solution. [Extracted from the article]

Researchers at the University of Zurich conducted a randomized trial to assess the survival of pulp in adult nonpainful posterior teeth with carious pulp exposure. The treatment involved complete caries excavation, direct pulp capping with mineral trioxide aggregate, and immediate restoration with composite resin. The study found that pulp lavage with a sodium hypochlorite solution significantly increased pulp survival compared to a control treatment with physiological saline solution. The research challenges the concept of direct pulp capping in these cases and suggests that inflammatory states of the pulp tissue under deep caries may not be related to neutrophil infiltration. [Extracted from the article]

A patent has been issued for a method of producing a medically-deliverable intravenous saline solution. The method involves supplying water to a housing, purifying the water, and then mixing a concentrated intravenous saline solution with the water to create the final solution. The solution can be administered intravenously to patients in various settings, including remote locations. The patent also describes a device that can be used to produce the solution. The inventors highlight the need for improvements in current intravenous solution delivery devices and methods. [Extracted from the article]

The B-CLASS study, a clinical trial known as NCT06177197, is set to investigate the use of electrodialyzed seawater as a treatment for acute infant bronchiolitis. The trial will be a multicenter, prospective, controlled, randomized, double-blind study. Infants aged 1 month to less than one year will be randomly assigned to either the experimental group (electrodialyzed seawater) or the control group (saline solution). The study will assess the duration of symptoms in both groups over a 21-day period. The recruitment for the study has not yet started, and the estimated completion date is February 1, 2027. [Extracted from the article]

The introduction of rootstocks for the guava has become necessary due to the advance of guava decline. Among them, Psidium spp. or their hybrids have been evaluated. In addition to disease resistance, tolerance to salinity must be evaluated in the new rootstocks. The aim of this study was to verify the effect of rootstocks and intergrafts on the mineral composition of Psidium spp. submitted to salt stress. The experiment was setup in a randomized block design, with the following treatments (scion/rootstock): P. guineense/P. cattleianum; P. guajava/P. guineense/P. cattleianum; P. guajava 'Paluma'/P. guajava; P. guajava 'Paluma'/P. guineense; P. guajava 'Cortibel 1'/P. guajava; P. guajava 'Cortibel 1'/P. guineense; P. cattleianum (purple) and P. cattleianum (yellow), with three replications and three plants per plot. The plants underwent irrigation with saline solution, and the levels of macronutrients, micronutrients and sodium in the scion leaves were evaluated. As rootstock, P. cattleianum results in greater Na uptake, with higher levels in the leaves of the scions, leading to less tolerance to salt stress. [ABSTRACT FROM AUTHOR]

A patent application has been submitted for a closed IV access device that provides secondary confirmation of proper catheter placement without requiring blood to flow into the extension tube. The device includes a catheter adapter, an extension tube, and a needle hub with a flash chamber. The flash chamber allows blood to flow into it when the needle tip is in a patient's vein, providing visual confirmation of proper catheter placement. The device also includes a path-defining structure to facilitate identification of blood flow into the flash chamber. The invention is beneficial in instances where the extension tube is pre-primed with saline solution. [Extracted from the article]

A recent study conducted by researchers from the Division of Plastic has found that a combination of autologous fat and platelet-rich plasma (PRP) injections can effectively reduce pain and improve hand function in patients with carpometacarpal arthritis of the thumb. The study involved 95 participants who were injected with either autologous fat, PRP, a combination of both, or a saline solution. The combination of fat and PRP was found to be the most effective treatment, resulting in significant pain reduction and improved quality of life. The researchers suggest that this treatment could be a safe alternative to short-acting glucocorticoids. [Extracted from the article]

A study conducted at the Affiliated Hospital of Nantong University aimed to determine the effectiveness and appropriate dosage of esketamine in preventing early postoperative pain in patients undergoing laparoscopic cholecystectomy. The study involved 54 patients who were randomly assigned to two groups, with one group receiving esketamine and the other receiving a saline solution. The researchers found that esketamine effectively prevented early postoperative pain, with an ED50 (median effective dose) of 0.301 mg/kg and an ED95 (95% effective dose) of 0.379 mg/kg. The study also found no significant difference in adverse reactions between the two groups. The findings suggest that esketamine may be a viable option for pain management in laparoscopic cholecystectomy patients. [Extracted from the article]

This document summarizes a clinical trial in Son Tay Province, Hanoi, Vietnam, that aims to evaluate the effectiveness of nasal-spraying probiotics in preventing respiratory diseases in children aged 2-6. The trial will involve 600 children who will be randomly divided into three groups, with one group receiving a saline solution and the other two groups receiving different types of probiotics. The primary outcome measures include the percentage of children with respiratory infections and the number of illness episodes. The study is being conducted by Anabio R&D in collaboration with Hanoi Medical University and is expected to be completed by September 30, 2024. [Extracted from the article]

A 53-year-old woman experienced treatment failure with norepinephrine, polidocanol, and sodium chloride for lower gastrointestinal bleeding. Despite attempts to stop the bleeding using various interventions, including rinsing the bleeding site with ice cold saline solution and norepinephrine, as well as using a titanium clip to clamp the vessels, the bleeding persisted. The woman eventually recovered after receiving fluid resuscitation, somatostatin therapy, and acid suppression. However, she later developed massive bleeding and underwent emergency angiography and embolization. She remained stable during follow-up visits. [Extracted from the article]

Aqsens Health Oy, a company based in Turku, Finland, has been issued a patent for a method of detecting a biomarker for prostate cancer. The patent describes a cost-effective and reliable method that can be used for pre-screening prostate cancer at home using a simple test kit. The method involves diluting a urine sample in a physiological saline solution, contacting it with a luminescent label and a modulating agent, incubating the sample, illuminating it with excitation light, and measuring the luminescence signal. The patent aims to provide a more accurate and efficient way of diagnosing aggressive prostate cancer and reducing the overdiagnosis and overtreatment of the disease. [Extracted from the article]

Both the saline and glucose solutions used in the IBO tool show promising results in effectively assessing PV occlusion." For more information on this research see: Accuracy of the Injection-Based Occlusion Tool Utilizing Saline and Glucose Solution in Cryoballoon Ablation Guided by a Novel Dielectric Imaging System. [Extracted from the article]

Barcelona, Spain, Europe, Cancer, Drugs and Therapies, Gynecology, Health and Medicine, Oncology, Ovarian Cancer, Women's Health Keywords: Barcelona; Spain; Europe; Cancer; Drugs and Therapies; Gynecology; Health and Medicine; Oncology; Ovarian Cancer; Women's Health EN Barcelona Spain Europe Cancer Drugs and Therapies Gynecology Health and Medicine Oncology Ovarian Cancer Women's Health 1128 1128 1 11/06/23 20231109 NES 231109 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on Oncology - Ovarian Cancer are discussed in a new report. [Extracted from the article]

Keywords: Becton Dickinson and Company; Business; Cardiovascular Diseases and Conditions; Drugs and Therapies; Health and Medicine; Healthcare Companies; Healthcare Technology Companies; Heparin Therapy; Medical Technology Companies; Pharmaceuticals; Risk and Prevention; Thrombosis EN Becton Dickinson and Company Business Cardiovascular Diseases and Conditions Drugs and Therapies Health and Medicine Healthcare Companies Healthcare Technology Companies Heparin Therapy Medical Technology Companies Pharmaceuticals Risk and Prevention Thrombosis 4516 4516 1 11/06/23 20231106 NES 231106 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- A patent by the inventors Anderson, Gregory (Columbus, NE, US), Bonczynski, Gerald Leon (Columbus, NE, US), Cojocariu, Gheorghe (Bridgewater, NJ, US), Erekovcanski, Nicholas (Butler, NJ, US), Fitz, Steve (Columbus, NE, US), Garrabrant, Samantha R. (Fair Lawn, NJ, US), Marici, Paul P. (Piscataway, NJ, US), San Solo, Shoshana (New York, NY, US), Timmers, Richard (Westwood, NJ, US), Tonniges, Bradley (Columbus, NE, US), filed on July 8, 2020, was published online on October 17, 2023, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Third, the fluid or pharmaceutical therapy is administered through the IV line or catheter (Administer therapy), the VAD connector is disinfected a third time, followed by a second Saline flush step. Second, a syringe containing saline is used to flush the IV line or catheter (Saline flush), and then the VAD connector is disinfected a second time. [Extracted from the article]

Keywords for this news article include: FDA, Therapy, Health and Medicine, U.S. Food and Drug Administration, Government Agencies Offices and Entities, Center for Devices and Radiological Health. Keywords: Center for Devices and Radiological Health; FDA; Government Agencies Offices and Entities; Health and Medicine; Therapy; U.S. Food and Drug Administration EN Center for Devices and Radiological Health FDA Government Agencies Offices and Entities Health and Medicine Therapy U.S. Food and Drug Administration 924 924 1 10/03/23 20231006 NES 231006 2023 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- The FDA has identified this as a Class I recall, the most serious type of recall. [Extracted from the article]